Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06264180
Title VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs (IGNYTE-3)
Acronym IGNYTE-3
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Replimune Inc.
Indications
Therapies
Age Groups: child | senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
The Angeles Clinic and Research Institute RECRUITING Los Angeles California 90025 United States Details
USC Norris Comprehensive Cancer Center RECRUITING Los Angeles California 90033 United States Details
UCSF Helen Diller Family Comprehensive Cancer Center RECRUITING San Francisco California 94143 United States Details
University of Iowa RECRUITING Iowa City Iowa 52242 United States Details
University of Louisville Brown Cancer Center RECRUITING Louisville Kentucky 40202 United States Details
Hackensack University Medical Center RECRUITING Hackensack New Jersey 07601 United States Details
Morristown Medical Center - Atlantic Health System RECRUITING Morristown New Jersey 07960 United States Details
Stony Brook University Cancer Center RECRUITING Stony Brook New York 11794 United States Details
Duke Cancer Center RECRUITING Durham North Carolina 27710 United States Details
Thomas Jefferson University RECRUITING Philadelphia Pennsylvania 19107 United States Details
UPMC RECRUITING Pittsburgh Pennsylvania 15232 United States Details
West Cancer Center and Research Institute RECRUITING Germantown Tennessee 38138 United States Details
University of Tennessee RECRUITING Knoxville Tennessee 37920 United States Details
Intermountain Health RECRUITING Murray Utah 84107 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field